Business Description
Praram 9 Hospital PCL
Description
Praram 9 Hospital PCL is engaged in hospital operations in Bangkok. The company operates an overnight general hospital under the name of Praram 9 Hospital. The revenue derived from hospital operations mainly consists of medical fees, hospital room sales, and medicine sales. Geographically, the company operates only in Thailand.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 184.01 |
N/A
|
N/A
| |||
Equity-to-Asset | 0.83 |
N/A
|
N/A
| |||
Debt-to-EBITDA | 0.01 |
N/A
|
N/A
| |||
Interest Coverage | 961.26 |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 9.19 | |||||
Beneish M-Score | -1.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.7 | |||||
3-Year EBITDA Growth Rate | 9.9 |
N/A
|
N/A
| |||
3-Year EPS without NRI Growth Rate | 13.4 |
N/A
|
N/A
| |||
3-Year FCF Growth Rate | -14.4 |
N/A
|
N/A
| |||
3-Year Book Growth Rate | 7.5 |
N/A
|
N/A
| |||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.89 |
N/A
|
N/A
| |||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.1 |
N/A
|
N/A
|
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.77 |
N/A
|
N/A
| |||
Quick Ratio | 3.69 |
N/A
|
N/A
| |||
Cash Ratio | 2.97 |
N/A
|
N/A
| |||
Days Inventory | 6.88 |
N/A
|
N/A
| |||
Days Sales Outstanding | 29.93 |
N/A
|
N/A
| |||
Days Payable | 68.24 |
N/A
|
N/A
|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.44 |
N/A
|
N/A
| |||
3-Year Dividend Growth Rate | 47.6 |
N/A
|
N/A
| |||
Shareholder Yield % | 2.73 |
N/A
|
N/A
|
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.24 |
N/A
|
N/A
| |||
Operating Margin % | 17.47 |
N/A
|
N/A
| |||
Net Margin % | 15.16 |
N/A
|
N/A
| |||
EBITDA Margin % | 24.7 |
N/A
|
N/A
| |||
FCF Margin % | 6.58 |
N/A
|
N/A
| |||
OCF Margin % | 16.07 |
N/A
|
N/A
| |||
ROE % | 13.9 |
N/A
|
N/A
| |||
ROA % | 11.68 |
N/A
|
N/A
| |||
ROIC % | 20.48 |
N/A
|
N/A
| |||
3-Year ROIIC % | 131.92 |
N/A
|
N/A
| |||
ROC (Joel Greenblatt) % | 30.2 |
N/A
|
N/A
| |||
ROCE % | 16.4 |
N/A
|
N/A
| |||
Years of Profitability over Past 10-Year | 10 |
N/A
|
N/A
|
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.72 |
N/A
|
N/A
| |||
Forward PE Ratio | 17.68 |
N/A
|
N/A
| |||
PE Ratio without NRI | 17.72 |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 23.59 |
N/A
|
N/A
| |||
PEG Ratio | 0.74 |
N/A
|
N/A
| |||
PS Ratio | 2.66 |
N/A
|
N/A
| |||
PB Ratio | 2.34 |
N/A
|
N/A
| |||
Price-to-Tangible-Book | 2.38 |
N/A
|
N/A
| |||
Price-to-Free-Cash-Flow | 40.45 |
N/A
|
N/A
| |||
Price-to-Operating-Cash-Flow | 16.56 |
N/A
|
N/A
| |||
EV-to-EBIT | 11.44 |
N/A
|
N/A
| |||
EV-to-Forward-EBIT | 17.11 |
N/A
|
N/A
| |||
EV-to-EBITDA | 8.64 |
N/A
|
N/A
| |||
EV-to-Forward-EBITDA | 11.97 |
N/A
|
N/A
| |||
EV-to-Revenue | 2.14 |
N/A
|
N/A
| |||
EV-to-Forward-Revenue | 2.77 |
N/A
|
N/A
| |||
EV-to-FCF | 32.45 |
N/A
|
N/A
| |||
Price-to-GF-Value | 0.76 |
N/A
|
N/A
| |||
Price-to-Projected-FCF | 1.29 |
N/A
|
N/A
| |||
Price-to-Peter-Lynch-Fair-Value | 0.84 |
N/A
|
N/A
| |||
Price-to-Graham-Number | 1.37 |
N/A
|
N/A
| |||
| Price-to-Net-Current-Asset-Value | 6.04 |
N/A
|
N/A
| |||
| Price-to-Net-Cash | 8.92 |
N/A
|
N/A
| |||
Earnings Yield (Greenblatt) % | 8.74 |
N/A
|
N/A
| |||
FCF Yield % | 2.47 |
N/A
|
N/A
| |||
Forward Rate of Return (Yacktman) % | 23.89 |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Praram 9 Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 5,321.33 | ||
| EPS (TTM) (฿) | 1.02 | ||
| Beta | -0.01 | ||
| 3-Year Sharpe Ratio | -61.75 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 1.83 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (฿) | - | ||
| 20-Day SMA (฿) | 18.9 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (฿) | 18.9 - 18.9 | ||
| Shares Outstanding (Mil) | 786.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Praram 9 Hospital PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Praram 9 Hospital PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.300000 Cash Dividend | 2026-04-30 | 18.90 (+0.00%) | ||
| THB 0.200000 Cash Dividend | 2025-11-20 | 18.90 (+0.00%) | ||
| THB 0.250000 Cash Dividend | 2025-05-07 | 18.90 (+0.00%) | ||
| THB 0.150000 Cash Dividend | 2024-11-22 | 18.90 (+0.00%) |
Show
Entries
Praram 9 Hospital PCL Frequently Asked Questions
What is Praram 9 Hospital PCL(BKK:PR9-F)'s stock price today?
The current price of BKK:PR9-F is ฿18.90. The 52 week high of BKK:PR9-F is ฿18.90 and 52 week low is ฿18.90.
When is next earnings date of Praram 9 Hospital PCL(BKK:PR9-F)?
The next earnings date of Praram 9 Hospital PCL(BKK:PR9-F) is .
Does Praram 9 Hospital PCL(BKK:PR9-F) pay dividends? If so, how much?
Praram 9 Hospital PCL(BKK:PR9-F) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Praram 9 Hospital PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers